Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youth treated with tenofovir disoproxil fumarate

Lignende værker

• Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?
  af: Havens, Peter L., et al.
  Udgivet: (2013)
• The Place of Tenofovir Disoproxil Fumarate in Pediatric Antiretroviral Therapy
  af: Havens, Peter L., et al.
  Udgivet: (2015)
• Vitamin D3 Decreases Parathyroid Hormone in HIV-Infected Youth Being Treated With Tenofovir: A Randomized, Placebo-Controlled Trial
  af: Havens, Peter L., et al.
  Udgivet: (2012)
• Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial
  af: Havens, Peter L, et al.
  Udgivet: (2018)
• Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis
  af: Havens, Peter L., et al.
  Udgivet: (2017)